Aetna Subrogation and Pharmacy Liens in Personal Injury Settlements

James Wong — Founder & Pharmacist, LienScripts | February 16, 2026 | 8 min read

Aetna — now part of CVS Health — operates one of the most aggressive subrogation programs in the U.S. health insurance market. Understanding how Aetna pursues PI settlement recovery, when ERISA preemption applies, how the made-whole doctrine interacts with Aetna's reimbursement demands, and why pharmacy liens for injury medications fall outside Aetna's subrogation interest is essential for PI attorneys distributing settlements.

This post is for informational purposes only and does not constitute legal advice.

Aetna as a CVS Health Subsidiary: What Changed

Aetna was acquired by CVS Health Corporation in 2018, creating one of the largest integrated health services companies in the United States. For personal injury attorneys, the acquisition's most significant practical consequence is Aetna's positioning at the intersection of health insurance, pharmacy benefits management, and subrogation — all within the same corporate umbrella.

Aetna continues to operate under its own brand as a health insurer and benefit plan administrator. Its subrogation recovery operations are conducted through Aetna's dedicated recovery unit, which pursues reimbursement from PI and workers' compensation settlements across the country. Aetna's subrogation program is well-resourced, data-driven, and aggressive — it is one of the more sophisticated recovery operations in the industry.

For PI attorneys, this matters because Aetna subrogation claims appear on a wide range of matters — employer-sponsored health plans, individual policies, and Medicaid managed care arrangements — and the legal framework governing each is different.

[!KEY] Aetna's subrogation unit is one of the most active in the country. Attorneys who raise made-whole and common fund defenses early — with organized documentation — consistently achieve greater reductions than those who wait for Aetna to drive the negotiation timeline.

How Aetna Pursues Recovery from PI Settlements

Aetna's subrogation process is systematic. When Aetna identifies a plan member who has received treatment for an injury that may involve a third-party liability claim, it opens a subrogation file. The process typically proceeds as follows:

1. Identification. Aetna's claims data flags injury-related treatment (ICD codes for injuries caused by external events) that suggests a third-party claim may exist.
2. Lien notice. Aetna (or its subrogation vendor) contacts the plan member and, where it has attorney contact information, the handling attorney to assert a subrogation interest.
3. Claims inventory. Aetna compiles a list of all benefits paid in connection with the injury — medical claims, possibly pharmacy claims if your client used Aetna's pharmacy benefit.
4. Settlement monitoring. Aetna tracks the case and expects notice of settlement.
5. Final demand. Upon settlement, Aetna issues a formal subrogation demand for the identified benefits paid.
6. Reduction negotiation. The attorney presents applicable defenses — made-whole, common fund, causation — and a negotiated amount is agreed in writing.

Aetna uses third-party subrogation vendors in some cases. If you receive a subrogation notice from a vendor rather than Aetna directly, confirm the relationship and verify the benefits-paid figure against the plan's records.

Fully Insured Aetna Plans vs. ERISA Self-Funded Plans

The most important threshold question in any Aetna subrogation matter is: Is this a fully insured plan or an ERISA self-funded plan?

Fully insured Aetna plans. Aetna itself bears the insurance risk. State insurance law governs. State-law made-whole doctrines and anti-subrogation statutes apply and can reduce or eliminate Aetna's reimbursement demand. This is the more plaintiff-protective scenario.

ERISA self-funded plans administered by Aetna. Many large employers self-fund their health benefits and hire Aetna as the third-party administrator. ERISA preempts state insurance laws, including state made-whole statutes, for self-funded plans. The plan document governs. This is the more challenging scenario.

The determination is made by reviewing the Summary Plan Description. A fully insured plan's SPD will identify Aetna as the insurer. A self-funded plan's SPD will typically say that the employer is the plan sponsor and that the plan is self-funded, with Aetna identified as the administrator.

[!SOURCE] US Airways, Inc. v. McCutchen, 569 U.S. 88 (2013): The Supreme Court confirmed that ERISA plan terms control subrogation in self-funded ERISA plans, but equitable gap-fillers like the common fund doctrine apply when the plan document is silent on the issue. Montanile v. Board of Trustees, 577 U.S. 136 (2016): ERISA plan subrogation liens attach only to specifically identifiable funds — the plan's equitable lien does not extend to dissipated proceeds.

The Made-Whole Doctrine and Aetna

For fully insured Aetna plans, the made-whole doctrine is the primary reduction tool. Under this doctrine, Aetna cannot recover subrogation until the plaintiff is fully compensated. If the at-fault party's policy limits did not fully cover the plaintiff's damages, the made-whole argument is available.

Building the made-whole record. The made-whole defense requires demonstrating that total damages exceed the settlement recovery. Document all components of special damages: medical bills, pharmacy lien balances, lost wages, out-of-pocket expenses, future medical needs. The pharmacy lien balance — the full outstanding amount owed to the lien pharmacy — is a legitimate special damages component and should be included in the total damages figure when presenting a made-whole argument to Aetna.

Aetna's response. Aetna's recovery unit receives made-whole requests regularly and has an internal review process. A well-organized submission — listing total damages, settlement amount, the gap, and the applicable legal standard — is processed more efficiently and results in better outcomes than an informal verbal argument.

For ERISA self-funded plans, the made-whole doctrine as a state law matter is preempted. However, some courts have recognized a federal common law equitable made-whole principle that applies as a gap-filler under McCutchen when the plan document is silent. The strength of this argument depends on the circuit and the specific plan language.

Causation Challenges: Disputing the Benefits Paid List

One often-overlooked Aetna reduction strategy is challenging causation on individual line items. Aetna's benefits-paid list is generated from claims data and may include items that predate the accident, relate to unconnected conditions, or are associated with the injury only peripherally. Reviewing the claims list line by line against the medical records can identify challenges to individual items and reduce the base amount subject to subrogation before applying made-whole or common fund reductions.

Common Fund Reduction

The common fund doctrine provides that Aetna, having benefited from the attorney's work in creating the settlement fund, must contribute a proportionate share of attorney fees and costs. This reduction is available for fully insured plans and, under McCutchen, for self-funded ERISA plans where the plan document is silent on the issue.

Present the common fund fee calculation simultaneously with the made-whole argument in a single organized submission. This gives Aetna's recovery unit the complete record it needs to approve a multi-pronged reduction at once, rather than sequentially.

What Aetna's Subrogation Interest Covers — and What It Does Not

Aetna's subrogation interest covers benefits the health plan actually paid for your client's injury-related care. This includes hospital bills, physician fees, specialist visits, imaging, procedures, and any pharmacy benefits paid through the Aetna Pharmacy benefit.

What it does not cover. Medications dispensed through a pharmacy lien arrangement are entirely outside Aetna's subrogation interest. When your client's injury medications are provided by a lien-based pharmacy — medications the patient accesses on credit, to be repaid from the settlement — those prescriptions are never submitted to Aetna and never paid by Aetna. There is no Aetna claim to recover because Aetna never paid for those medications.

This is not a technicality — it reflects the fundamental structure of the pharmacy lien model. The pharmacy lien provider extends credit to the patient. No insurance claim is filed. No payment is made by any insurer. Aetna has nothing to recover on prescriptions it never paid for.

[!KEY] Proactively enrolling injury clients in a pharmacy lien program at intake eliminates Aetna's subrogation exposure on all injury medications — not by reducing Aetna's reimbursement, but by ensuring Aetna never pays for those medications in the first place. There is no subrogation interest to negotiate where there is no payment to recover.

The Aetna-CVS Integration: Pharmacy Benefits Coordination Considerations

Because CVS Health controls both Aetna (health plan) and CVS Caremark (pharmacy benefit manager), attorneys should be attentive to cases where your client's employer plan uses CVS Caremark as the pharmacy benefit manager alongside Aetna as the health insurer. In these cases, both medical and pharmacy benefits may flow through the same corporate family, and both may appear in Aetna's subrogation claims inventory.

This makes the separation of lien-dispensed prescriptions from Aetna/Caremark-covered prescriptions especially important. Lien medications dispensed by a lien pharmacy — not a CVS Caremark pharmacy using the client's Aetna benefit card — will not appear in Aetna's claims data and are outside the subrogation demand regardless of the Aetna-CVS integration.

When reviewing Aetna's benefits-paid list, verify that any pharmacy claims included were actually processed through the plan's pharmacy benefit — and not lien-dispensed medications that were incorrectly attributed.

Negotiating Aetna Subrogation: Practical Framework

For fully insured plans:

1. Identify the plan type and state law governing.
2. Document total special damages, including the pharmacy lien balance.
3. Calculate the made-whole gap (total damages minus settlement).
4. Calculate the common fund fee reduction (proportionate share of attorney fees).
5. Submit a single written reduction request with all three elements.
6. Confirm the reduced amount in writing before distributing.

For ERISA self-funded plans:

1. Obtain the plan document and Summary Plan Description.
2. Review for express provisions on common fund and made-whole.
3. Identify plan document gaps that permit equitable gap-filling under McCutchen.
4. Challenge causation on individual line items where appropriate.
5. Submit a written request citing the applicable plan document provisions and federal case law.
6. Obtain written final balance confirmation before distribution.

In both cases, confirm the pharmacy lien balance separately with LienScripts and obtain written release of the pharmacy lien before proceeds are distributed.

Settlement Waterfall with Aetna Subrogation

When Aetna has a subrogation claim and a pharmacy lien is also present, the typical PI settlement waterfall is:

1. Gross settlement received.
2. Attorney fees and costs deducted.
3. All lien claims identified: hospital, treating providers, pharmacy lien — and Aetna subrogation.
4. Aetna subrogation negotiated: made-whole, common fund, causation challenges applied; written final amount confirmed.
5. Pharmacy lien negotiated separately with LienScripts; written release obtained.
6. Net proceeds distributed to client.

The Aetna subrogation negotiation and the pharmacy lien negotiation are conducted independently and proceed in parallel — neither affects the other.

Practical Steps for Attorneys

1. At intake, identify whether your client has Aetna health coverage. Ask about current and past employer-sponsored health benefits.
2. Determine if the plan is fully insured or ERISA self-funded. Request the Summary Plan Description from the client or plan administrator.
3. Enroll the client in a pharmacy lien program early. This keeps all injury medications outside Aetna's claims system, eliminating any subrogation interest on those prescriptions.
4. Build the total damages record throughout the case. Include medical bills, pharmacy lien balances, lost wages, and future care costs.
5. Send Aetna's subrogation unit a settlement notice before distributing to protect against plan liability claims.
6. Submit a single organized reduction request addressing made-whole, common fund, and any causation challenges together.
7. Confirm both Aetna's release and the pharmacy lien release in writing before proceeding with distribution.

Key Takeaway

Aetna — now operating within the CVS Health corporate structure — runs one of the country's most active subrogation programs and will assert a recovery interest against PI settlements wherever benefits were paid. Whether state law or ERISA governs depends on whether the plan is fully insured or self-funded — a determination that drives the entire reduction strategy. Pharmacy liens for injury medications are entirely outside Aetna's subrogation interest: Aetna never pays for lien-dispensed prescriptions, so there is nothing for Aetna to recover on those medications. Managing the two separately, raising defenses early, and enrolling clients in pharmacy lien programs at intake is the most effective strategy for maximizing client recovery.

Related Resources

• Health Insurance Subrogation vs. Pharmacy Liens: California PI Attorney Guide
• State Farm MedPay and Subrogation in Personal Injury Cases
• GEICO MedPay and Pharmacy Lien Coordination in California
• Pharmacy Lien Settlement Waterfall in California PI Cases